Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Pablo Mandó

9PUBLICATIONS

35CO-AUTHORS

Molecular targetsLiquid biopsiesCancer diagnosisMultimorbidityPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Feb 12, 2026

<i>BRCA</i> and CDK4/6: allies or antagonists?-efficacy of CDK4/6 inhibitors in HR<sup>+</sup>/HER2<sup>-</sup> breast cancer with germline <i>BRCA1/2</i> mutations: a narrative review.

Maria Florencia Illia, Giuliana Colucci, Andres Rodriguez Mignola

|Dec 04, 2025

Challenges and Opportunities for Cancer Clinical Trials Development in Latin America.

Juan Manuel Garzón-Dangond, Oscar Arrieta, Pablo Mandó

|Oct 22, 2025

Physician treatment decisions for hormone receptor-positive, HER2-negative early breast cancer in young patients: a Latin American survey.

Dana Narvaez, Federico Waisberg, Cynthia Villarreal-Garza

|Apr 11, 2025

Academic Collaborative Groups in Latin America: Key for High-Quality Standards and Personal and Collective Growth.

Pablo Mandó, Federico Waisberg, Gonzalo Gomez Abuin

|Feb 27, 2025

Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022.

Sofie Seghers, Pablo Mandó, Marc Eid

|Nov 27, 2024

Uncovering Surgical Dynamics and Trends in Early Breast Cancer Stage at Diagnosis: Key Insights From a Two-Decade Argentine Database Analysis.

Pablo Mandó, Verónica Fabiano, Soledad Gomez Guasch

Pageof 2

Frequent Collaborators

5 joint publications

Federico Waisberg

2 joint publications

Carlos Barrios

2 joint publications

Andrés F Cardona

1 joint publications

Gerardo Cueto

1 joint publications

María Victoria Costanzo

1 joint publications

Ignacio Mc Lean

1 joint publications

Alejandro Mazzotta

1 joint publications

Janeth Lara Alcantara

1 joint publications

Liliana Gutiérrez-Babativa

1 joint publications

Mora Amat

Frequent Collaborators

5 joint publications

Federico Waisberg

2 joint publications

Carlos Barrios

2 joint publications

Andrés F Cardona

1 joint publications

Gerardo Cueto

Top Related Videos

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on : Feb 17, 2011

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

See more related videos

Top Related Videos

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on : Feb 17, 2011

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

See more related videos